EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Alpha 7 Nicotinic Acetylcholine Receptor Agonist PHA 568487 Reduces Acute Inflammation but Does Not Affect Cardiac Function or Myocardial Infarct Size in the Permanent Occlusion Model

Filip Mjörnstedt iD, Azra Miljanovic, Rebecka Wilhelmsson, Malin Levin, Maria E Johansson iD

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms25084414 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Filip Mjörnstedt und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology, Institute of Neuroscience and Physiology, The Sahlgrenska Academy, University of Gothenburg, 405 30 Gothenburg, Sweden. Hauptthemen laut MEDLINE: Myocardial Infarction, alpha7 Nicotinic Acetylcholine Receptor, Disease Models, Animal, Inflammation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Grants from the Swedish state under the agreement between the Swedish government and the county councils, the ALF-agreement, The swedish research Council, the Swedish Heart-Lung Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Stimulation of the alpha 7 nicotinic acetylcholine receptor (α7nAChR) has shown beneficial effects in several acute inflammatory disease models. This study aims to examine whether treatment with the selective α7nAChR agonist PHA 568487 can dampen inflammation and thereby improve cardiac function after myocardial infarction in mice. The possible anti-inflammatory properties of α7nAChR agonist PHA 568487 were tested in vivo using the air pouch model and in a permanent occlusion model of acute myocardial infarction in mice. Hematologic parameters and cytokine levels were determined. Infarct size and cardiac function were assessed via echocardiography 24 h and one week after the infarction. Treatment with α7nAChR agonist PHA 568487 decreased 12 (CCL27, CXCL5, IL6, CXCL10, CXCL11, CXCL1, CCL2, MIP1a, MIP2, CXCL16, CXCL12 and CCL25) out of 33 cytokines in the air pouch model of acute inflammation. However, α7nAChR agonist PHA 568487 did not alter infarct size, ejection fraction, cardiac output or stroke volume at 24 h or at 7 days after the myocardial infarction compared with control mice. In conclusion, despite promising immunomodulatory effects in the acute inflammatory air pouch model, α7nAChR agonist PHA 568487 did not affect infarct size or cardiac function after a permanent occlusion model of acute myocardial infarction in mice. Consequently, this study does not strengthen the hypothesis that stimulation of the α7nAChR is a future treatment strategy for acute myocardial infarction when reperfusion is lacking. However, whether other agonists of the α7nAChR can have different effects remains to be investigated.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Myocardial Infarctionalpha7 Nicotinic Acetylcholine ReceptorDisease Models, AnimalInflammationAnimalsMiceMaleCytokinesNicotinic AgonistsPyridinesMice, Inbred C57BLQuinuclidinesBenzylaminesBenzylidene Compounds

Stichwörter der Autor:innen

alpha 7 nicotinic acetylcholine receptor (α7nAChR)inflammationmyocardial infarctionα7nAChR agonist

Substanzen

alpha7 Nicotinic Acetylcholine ReceptorCytokinesNicotinic AgonistsPyridines3-(2,4-dimethoxybenzylidene)anabaseineQuinuclidinesBenzylaminesBenzylidene Compounds

Autor:innen und Institutionen

  • Department of Physiology, Institute of Neuroscience and Physiology, The Sahlgrenska Academy, University of Gothenburg, 405 30 Gothenburg, Sweden.
  • Wallenberg Laboratory, Department of Molecular and Clinical Medicine, Institute of Medicine, The Sahlgrenska Academy, University of Gothenburg, 413 45 Gothenburg, Sweden.

ORCID-Profile: Filip Mjörnstedt, Maria E Johansson

Förderung

  • Grants from the Swedish state under the agreement between the Swedish government and the county councils, the ALF-agreement
  • The swedish research Council
  • the Swedish Heart-Lung Foundation
  • Mary von Sydow foundation
  • Stiftelsen Gamla tjänarinnor
  • Stiftelsen Tornspiran
  • Dr. Felix Neuberghs Foundation
  • Wilhelm and Martina Lundgren foundation

Zitieren

APA

Mjörnstedt, F., Miljanovic, A., Wilhelmsson, R., Levin, M., & Johansson, M. E. (2024). Alpha 7 Nicotinic Acetylcholine Receptor Agonist PHA 568487 Reduces Acute Inflammation but Does Not Affect Cardiac Function or Myocardial Infarct Size in the Permanent Occlusion Model. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25084414

Vancouver

Mjörnstedt F, Miljanovic A, Wilhelmsson R, Levin M, Johansson ME. Alpha 7 Nicotinic Acetylcholine Receptor Agonist PHA 568487 Reduces Acute Inflammation but Does Not Affect Cardiac Function or Myocardial Infarct Size in the Permanent Occlusion Model. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25084414

BibTeX
@article{Mjrnstedt2024,
  author = {Mjörnstedt, Filip and Miljanovic, Azra and Wilhelmsson, Rebecka and Levin, Malin and Johansson, Maria E},
  title = {Alpha 7 Nicotinic Acetylcholine Receptor Agonist PHA 568487 Reduces Acute Inflammation but Does Not Affect Cardiac Function or Myocardial Infarct Size in the Permanent Occlusion Model},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms25084414}
}
Kostenlos starten →